Light therapy takes aim at tough pancreatic tumors

NCT ID NCT05919238

Recruiting now Disease control Sponsor: Impact Biotech Ltd Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage trial tests a new treatment for people with advanced pancreatic cancer that cannot be removed by surgery. The therapy uses a light-sensitive drug and a special light delivered through a thin tube into the blood vessels feeding the tumor. The goal is to see if it is safe and can shrink the cancer, possibly making it operable. About 30 adults with stage III pancreatic cancer will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED UNRESECTABLE PANCREATIC ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

pancreatic adenocarcinoma pancreatic ductal adenocarcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LOCALLY ADVANCED UNRESECTABLE PANCREATIC ADENOCARCINOMA

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

City of Hope
RECRUITING

Duarte, California, 91010, United States

Contact
University of California Irvine
RECRUITING

Irvine, California, 92697, United States

Contact